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Summary Low field strength (0.08 Tesla) magnetic resonance imaging (MRI) of the spleen with spin lattice
relaxation time (T1) measurement was performed on a total of 79 healthy volunteers and 62 patients with
lymphoma. Inhomogeneity was observed on the T1 images of the spleen from 25 volunteers. This was
therefore considered a normal variant. The normal range of spleen T1 at 0.08 Tesla was established (362-
420msec). No influence of age on spleen T, was detected. The range of T, values observed in males and
females was similar, although the mean spleen T1 for females was significantly longer than that for males.
The sensitivity of T, measurement for the detection of lymphoma in the spleen was poor, particularly for
patients with Hodgkin's disease. In a minority of untreated patients, however, a spleen T1 value outside the
normal range may indicate the presence of lymphoma in the spleen. A significant decrease in spleen T, following treatment was observed in 9 patients who underwent serial scanning.
Accurate assessment of splenic involvement can be of great
importance for the selection of appropriate treatment for
patients with lymphoma. For example, mantle radiotherapy
may be the treatment of choice for patients with localized
supradiaphragmatic Hodgkin's disease (HD), but is clearly
inappropriate in the presence of lymphoma in the spleen. At
present laparotomy with splenectomy is the only accurate
method for assessing such cases. Clinical examination of the
spleen is frequently an unreliable guide to the presence or
absence of lymphoma. Lymphomatous infiltration may occur
in normal sized spleens (Goffinet et al., 1973; Kadin et al.,
1971). Conversely, an enlarged spleen (particularly in
patients with HD) does not always indicate the presence of
lymphoma (Glatstein et al., 1970; Sutcliffe et al., 1976). CT
scanning, radionuclide imaging and ultrasonography can
help in the assessment of splenic size and may detect the
presence of focal deposits, but the overall accuracy of each
of these methods for detecting splenic lymphoma is poor
(Best et al., 1978; Milder et al., 1973; Silverman et al., 1972;
Zornosa & Ginaldi, 1981).
This study has been undertaken to assess the accuracy of
low field strength (0.08 Tesla) magnetic resonance imaging
(MRI) with spin lattice relaxation time (T1) measurement in
the detection of splenic involvement by lymphoma.
Patients and methods
Volunteers andpatients
Seventy nine healthy volunteers were examined to assess the
normal appearance of the spleen on MRI and to establish
the normal range of spleen T1. Their characteristics are
shown in Table I.
Sixty two patients underwent MRI of the spleen. Nine
patients were scanned on 2 occasions giving a total of 71
scans. The diagnosis and clinical status of these patients are
shown in Table II.
Assessment ofsplenic involvement
Comparison of the results of MRI with histological
assessment of the spleen was possible in 19 of the 62
patients. In 18 of these splenectomy was performed within 2
weeks of imaging (Table III). For these cases the size of the
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spleen on MRI was compared with the weight measured
following splenectomy. In one case histological assessment
was made at autopsy.
Direct assessment of splenic involvement was not available
in the other 43 patients. It is not possible to exclude the
presence of splenic lymphoma in any of these cases. Twenty
one of the patients were classified as having 'probable'
splenic involvement based on the presence of at least one of
the following features, each of which has been previously
shown from laparotomy studies to be a strong indicator of
the presence of splenic lymphoma (Aisenberg et al., 1971;
Goffinet et al., 1973; Glatstein et al., 1970, Stein et al.,
1976):
1. Biopsy proven hepatic lymphoma.
2. Bone marrow infiltration by lymphoma.
3. Moderate (>4cm) splenomegaly in patients with non
Hodgkin's lymphoma (NHL).
4. Gross (>IOcm) splenomegaly in patients with HD.
The remaining patients for whom direct histological
assessment of the spleen was not available were classified as
having 'possible' splenic involvement.
Scanningprocedure
Axial images of the spleen were made in all patients and
volunteers using a 'MD 800' resistive magnetic resonance
imager operating at 0.08 Tesla (3.4MHz). A standard pulse
sequence'with alternating saturation recovery and inversion
recovery sequences with a repetition time of 1000msec and
an inversion time of 200msec was used for all examinations.
A calculated T1 image is generated from a computed
algorithm. The accuracy and reproducibility of T1 measure-
ments using this type of imager have been previously
reported (Redpath, 1982; Richards et al., 1988a). The
homogeneity of the appearance of the spleen on T1 images
was assessed. Inhomogeneity was classified as either focal
(with 'hot spots' ofhigh T1) or diffuse.
T, measurements were recorded from representative areas
of the spleen using region of interest cursors measuring
either 2cm2 or 4cm2. Measurements were made only from
sections in which the margins of the spleen were clearly
defined. Images taken through the upper and lower poles of
the spleen had ill defined outlines and were therefore not
measured in order to avoid partial volume effects. Similarly
the region of interest cursors were not placed within 10mm
of the periphery of the spleen images. Areas of high T1
immediately adjacent to the splenic hilum were assumed to
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be due to blood vessels and were excluded from the assess-
ment of spleen T1. All other areas of high or low T1 were
included in the measurements. The number of measurements
made on each subject ranged from 4 to 11 (median 7). The
mean spleen T1 for each subject was calculated from these
values. The reproducibility of calculation of mean spleen T1
was assessed by repeating the measurements on 20 of the
scans after an interval of 3 months. The maximum difference
observed in the estimation of mean spleen T1 was 12msec,
representing a change of 3%. In 16 of the 20 cases the
difference in the 2 measurements was 5 msec or less.
Results
Volunteers
In 54 of the 79 volunteers (68%) the spleen appeared
homogeneous on the calculated T1 images. In the other 25
cases inhomogeneity was detected. Ten had isolated focal
'hot spots' of high T1. one had a focal area of low T1p 12
had diffuse inhomogeneity of T1 and a further 2 had both
focal 'hot spots' and a background of diffuse inhomogeneity.
The focal areas of high T1 varied in size (from 1 cm2 to
8 cm2), shape and location within the spleen. The presence of
inhomogeneity was not related either to sex or age. The
volunteer with the largest focal area of high T1 was
rescanned after an interval of 3 months, at which time the
abnormality was not detectable. Because of the high inci-
dence of inhomogeneity of normal spleens on calculated T1
images this was considered to be a normal variant and was
not used as a criterion of abnormality in patients with
lymphoma.
Mean Spleen T1 for the 79 volunteers ranged between
362msec and 420msec (mean 385msec standard deviation
14msec). The range of spleen T1 for males (362-413msec)
and females (363-420msec) was similar. The mean value for
females (390msec) was, however, significantly higher than
that for males (379msec) - P<0.001. The influence of age
on spleen T1 was assessed separately for males and females.
No effect was observed in either group. Eighteen of the 34
females under the age of 40 years were oral contraceptive
users. The mean spleen T1 for these 18 was 390msec
compared with 389msec for the 16 who were not taking the
pill (P=0.8).
Patients with known splenic histology
Size on MRI compared with weight and histology (Table
IV) Six patients had enlarged spleens on MRI. In 3 of
Table I Characteristics of volunteers
Males Females Total
Age<40 years 23 34 57
Age>40 years 9 13 22
Total 32 47 79
Table II Characteristics ofpatients
HD NHL Total
Treatment Status (at time of first scan)
1. Previously untreated 23 (3)* 17 (5) 40 (8)
2. Post therapy 5 4 9
3. At relapse 8 5 (1) 13 (1)
Total 36 (3) 26 (6) 62 (9)
*Parentheses denote numbers of patients who also underwent
follow up MRI of the spleen.
Table III Characteristics of patients
splenectomy
undergoing
N= 18
Males 14 HD 14
Females 4 NHL 4
Age range 18-81 years (median 40 years)
Indicationfor splenectomy
HD NHL
Staging 9 0
Diagnostic 1 I
Post treatment re-evaluation 2 1
Therapeutic 2 2
(In an additional case the spleen was examined at
autopsy).
Table IV Results of splenectomy and MRI
Splenectomyfindings MRIfindings
Treatment Weight
Pt Diagnosis status Histology (g) Size T
1 HD 1 - 120 N N
2 HD 1 - 60 N N
3 HD 1 - 170 N N
4 HD 1 - 140 N N
5 HD 1 - 150 N low
6 HD 1 - 100 N N
7 HD 1 + 240 N low
8 HD 1 - 75 N N
9 HD 1 - 225 N N
10 HD 1 + 485 + N
11 HD 3 + >2,000 +++ N
12 HD 3 + 230 N low
13 HD 2 - 210 N N
14 HD 2 - 85 N low
15 NHL 1 + >2,000 + + + high
16 NHL 1 + 450 + N
17 NHL 1 + >2,000 + + + high
18 NHL 2 - 80 N N
19 HD 4 + enlarged + low
Treatment Status: 1=previously untreated; 2=post treatment: in clinical remission;
3 =relapse; 4=post mortem assessment of spleen. Size: N =normal; + =moderately
enlarged; +++ =massively enlarged. Spleen T1: N=normal; low= <362msec;
high = >420msec. Histology: - = no lymphoma in spleen; + =lymphoma in spleen.
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these the spleen appeared grossly enlarged. In each case the
spleen weighed more than 2,000g. In the other 3 cases the
spleen appeared moderately enlarged on MRI. The weights
for two of these were 450g and 485 g. In the autopsy case
the weight was not recorded but the spleen was described as
enlarged. In the remaining 13 cases the spleen was normal in
size on MRI and the weights ranged from 60-240g.
Eight of the 19 patients had histological evidence of
splenic lymphoma (5 out of 15 patients with HD, 3 out of 4
patients with NHL). All 6 cases in which the spleen was
enlarged on MRI were histologically positive. The other 2
cases in which histological evidence of lymphoma was found
weighed 230 and 240g, but were considered to be of normal
size on MRI.
T1 measurements in patients with known spleen histology
(Figure 1). Two of the 5 patients with HD in the spleen
had normal spleen T, (Figure 1, column 3). In one of these
cases deposits of HD measuring up to 3 cm in diameter were
found on histological examination of the spleen. Spleen T1
was below the normal range in the other 3 patients with HD
in the spleen. Two of the 3 patients with low T1 had received
previous chemotherapy and the other had recently under-
gone lymphography.
Two of the 3 patients with histologically proven NHL in
the spleen had prolonged spleen T1 (Figure 1, column 4). In
both cases the spleen was enlarged clinically and on MRI.
The third had normal spleen T1.
Histological examination of the spleen was negative for
lymphoma in 11 of the 19 patients (Figure 1, columns 2 and
5). Nine of these had normal spleen T1. The other 2 had low
spleen T1. Both of these patients had recently undergone
lymphography. One had also recently completed chemo-
therapy. Histology of the spleen in this case showed hypo-
cellular areas of fibrosis and the presence of fat vacuoles.
Spleen T1 results from all patients (Figure 2). The range of
spleen T1 observed from all 71 examinations was 307-
469msec. Values outside the normal range were observed on
26 occasions, 13 being above the upper limit of normal
(420msec) and 13 below the lower limit of normal
(362msec). T1 measurements for patients with definite (i.e.
histologically proven), 'probable' and 'possible' splenic
involvement are shown in Figure 2. Results from scans taken
during or after therapy are shown separately from those
taken before treatment or at relapse.
Hodgkin's disease. Two out of 15 patients with definite or
probable HD in the spleen had prolonged T1 (Figure 2,
column 2). Both were scanned at the time of relapse. A
further 7 patients in this group had normal T1, while in the
remaining 6 cases the T1 was below the normal range. Three
of the patients with low values had neither received any
treatment nor undergone lymphography. All 8 patients with
possible (but not probable) splenic HD had normal T1
(Figure 2, column 3).
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*Results from one patient are shown twice (columns 2 and 7).
This patient had recently received chemotherapy and was found to
have HD in the spleen at autopsy.
Figure 2 Spleen T1: Results from all patients.
Non Hodgkin's lymphoma. Nine out of 14 patients with
definite or probable NHL in the spleen had prolonged spleen
T1 (Figure 2, column 5). Values for the other 5 patients were
normal (including one patient with definite NHL in the
spleen). Two of the 8 patients classified as having possible
rather than probable splenic involvement had prolonged T1
(Figure 2, column 6). No previously untreated patient with
NHL had subnormal spleen T1.
Effect of therapy. A total of 18 patients (9 HD, 9 NHL)
were scanned during the course of chemotherapy or shortly
after its completion. Seven of these (4 HD, 3 NHL) had T1
values below the normal range. Six of the 7 with low T1 had
shown a good response to therapy. The other failed to
respond and had HD in the spleen at autopsy.
Results for the 9 patients who were scanned before and
after receiving treatment are shown in Figure 3. In each case
the T1 decreased following therapy, including one patient
who had only received radiotherapy to an area not involving
the spleen. T1 values before and after treatment for the 8
patients who received systemic therapy were compared using
a paired t test. The fall in T1 was highly significant
(P<0.001).
Discussion
The results of this study are disappointing. In contrast to
our findings for the liver (Richards et al., 1986), measure-
ment of spleen T1 by low field strength MRI is an insensitive
method for detecting involvement by lymphoma. The
sensitivity was particularly poor in patients with HD, for
whom the diagnosis of splenic involvement is clinically most
important. Normal, high and low T1 values were observed in
association with definite or probable HD in the spleen.
The sensitivity of T1 measurement was somewhat better in
patients with NHL. Two out of 3 patients with proven NHL
in the spleen and a further 7 out of 11 patients with
probable splenic lymphoma had prolonged T1. However, all
9 of these patients with abnormal T1 had splenomegaly,
which in patients with NHL is itself a reasonable indicator
of involvement (Goffinet et al., 1973). T1 measurement
therefore contributed little if anything to the overall
assessment. In two other patients (both classified as having
'possible' involvement), prolonged spleen T1 was observed in
the absence of splenomegaly. The presence of lymphoma in
the spleen in one of these cases is doubtful, as spleen T1
returned to normal after the patient had been treated with
radiotherapy to a distant site.
The p,oor sensitivity of T1 measurement for the detection lwl
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Figure 3 Spleen T1 pre and post treatment.
of splenic lymphoma cannot be attributed simply to a failure
to detect small tumour deposits. One patient had normal T1
in the presence of large masses of HD in the spleen.
Preliminary data indicate that lymphomatous node masses
have T, similar to that of normal spleen (Richards, 1987a).
If the T1 of lymphoma in the spleen is similar to that in
nodes, this would explain the difficulty in detecting splenic
lymphomea either by T, measurement or visually on T
images.
A significant decrease in T, following therapy was
observed in all patients examined before and after therapy.
In some cases the post-treatment value was subnormal.
While this might in part be due to successful treatment of
tumour in the spleen, it could also be due to effects of
chemotherapy on normal spleen T1. Spleen T1 has been
reported to decrease in healthy animals exposed either to
radiotherapy or to toxins (Bakker & Vriend, 1983; Ling &
Foster, 1980). The fall in T1 could be caused either by an
accumulation of red blood cell debris (with a high para-
magnetic iron content) or by a decrease in the water content
of the spleen (Ling & Foster, 1980).
The relatively high incidence (32%) of inhomogeneity of
spleen T1 in healthy volunteers was unexpected. The
presence of either focal areas of abnormal T1 or of diffuse
inhomogeneity on T1 images from patients should not be
interpreted as evidence of pathology. The inhomogeneity of
splenic T1 contrasts with the generally uniform appearance
of other normal tissues on T1 images made using the same
scanner (Richards et al., 1988a,b). The anatomical basis for
either the focal or the diffuse inhomogeneity found on
images of the spleen in volunteers is unknown. The single
case in which a large 'hot spot' was detected on one scan but
not on a similar image taken 3 months later makes it
unlikely that this appearance was due to a fixed anatomical
structure such as a blood vessel.
Although the mean T1 of the spleen was significantly
higher in females than in males the ranges of values observed
in both sexes was similar. Consequently, a single normal
range of T1 can be used for assessing results of splenic T1
made in patients. Spleen T1 was not affected by age. This
differs from our findings for either liver or bone marrow
(Richards et al., 1988a,b).
In conclusion, splenic T1 and size measurement made by
low field strength MRI are insensitive methods for detecting
splenic involvement by lymphoma. In a minority of cases,
however, the presence of a subnormal T1 in previously
untreated patients with HD or the presence of an elevated T1
in a patient with either HD or NHL may indicate the
presence of lymphoma in the spleen.
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